2010 Scrip 100 - The peaks and troughs of private investment
This article was originally published in Scrip
The past year has been a rollercoaster of a ride for the private investment market. The US continues to lead the way by a long shot, although robust business strategies have allowed some European biotechs to make their presence felt. And the return of the biotech IPO, while long awaited, is delivering mixed blessings, reports Simon Varcoe.